These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Allergy Work-Up Including Component-Resolved Diagnosis: How to Make Allergen-Specific Immunotherapy More Specific. Kleine-Tebbe J; Matricardi PM; Hamilton RG Immunol Allergy Clin North Am; 2016 Feb; 36(1):191-203. PubMed ID: 26617235 [TBL] [Abstract][Full Text] [Related]
23. Targeting dendritic cells in allergen immunotherapy. Novak N Immunol Allergy Clin North Am; 2006 May; 26(2):307-19, viii. PubMed ID: 16701146 [TBL] [Abstract][Full Text] [Related]
24. Scientific foundations of allergen-specific immunotherapy for allergic disease. Soyka MB; van de Veen W; Holzmann D; Akdis M; Akdis CA Chest; 2014 Nov; 146(5):1347-1357. PubMed ID: 25367471 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy. Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228 [TBL] [Abstract][Full Text] [Related]
26. B-cell responses in allergen immunotherapy. Satitsuksanoa P; van de Veen W; Akdis M Curr Opin Allergy Clin Immunol; 2019 Dec; 19(6):632-639. PubMed ID: 31403482 [TBL] [Abstract][Full Text] [Related]
27. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
29. A review of allergy and allergen specific immunotherapy. Bidad K; Nicknam MH; Farid R Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):1-9. PubMed ID: 21358009 [TBL] [Abstract][Full Text] [Related]
30. Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies. Kerekov N; Michova A; Muhtarova M; Nikolov G; Mihaylova N; Petrunov B; Nikolova M; Tchorbanov A Immunobiology; 2014 Jan; 219(1):45-52. PubMed ID: 24021574 [TBL] [Abstract][Full Text] [Related]
31. Immunological approaches for tolerance induction in allergy. Conrad ML; Renz H; Blaser K Curr Top Microbiol Immunol; 2011; 352():1-26. PubMed ID: 21598104 [TBL] [Abstract][Full Text] [Related]
32. Cloning allergen-specific antibody fragments (Fabs); tools for allergen standardization and therapy of type I allergy. Valenta R; Steinberger P; Laffer S; Dolecek C; Wiedemann P; Flicker S; Kraft D Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):222-9. PubMed ID: 9383913 [TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin G in IgE-mediated allergy and allergen-specific immunotherapy. Hofmaier S; Comberiati P; Matricardi PM Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):6-11. PubMed ID: 24702866 [TBL] [Abstract][Full Text] [Related]
35. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
36. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis. Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623 [TBL] [Abstract][Full Text] [Related]